These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

702 related items for PubMed ID: 31348506

  • 1. Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder.
    Sultan RS, Wang S, Crystal S, Olfson M.
    JAMA Netw Open; 2019 Jul 03; 2(7):e197850. PubMed ID: 31348506
    [Abstract] [Full Text] [Related]

  • 2. Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.
    Sikirica V, Pliszka SR, Betts KA, Hodgkins P, Samuelson T, Xie J, Erder H, Dammerman R, Robertson B, Wu EQ.
    J Manag Care Pharm; 2012 Jul 03; 18(9):676-89. PubMed ID: 23206211
    [Abstract] [Full Text] [Related]

  • 3. Lack of effect of stimulant combination with second-generation antipsychotics on weight gain, metabolic changes, prolactin levels, and sedation in youth with clinically relevant aggression or oppositionality.
    Penzner JB, Dudas M, Saito E, Olshanskiy V, Parikh UH, Kapoor S, Chekuri R, Gadaleta D, Avedon J, Sheridan EM, Randell J, Malhotra AK, Kane JM, Correll CU.
    J Child Adolesc Psychopharmacol; 2009 Oct 03; 19(5):563-73. PubMed ID: 19877981
    [Abstract] [Full Text] [Related]

  • 4. Stimulant and atypical antipsychotic medications for children placed in foster homes.
    Linares LO, Martinez-Martin N, Castellanos FX.
    PLoS One; 2013 Oct 03; 8(1):e54152. PubMed ID: 23326588
    [Abstract] [Full Text] [Related]

  • 5. Predictors of concomitant use of antipsychotics and stimulants and its impact on stimulant persistence in pediatric attention deficit hyperactivity disorder.
    Bali V, Kamble PS, Aparasu RR.
    J Manag Care Spec Pharm; 2015 Jun 03; 21(6):486-98. PubMed ID: 26011550
    [Abstract] [Full Text] [Related]

  • 6. A Naturalistic Comparison of Methylphenidate and Risperidone Monotherapy in Drug-Naive Youth With Attention-Deficit/Hyperactivity Disorder Comorbid With Oppositional Defiant Disorder and Aggression.
    Masi G, Manfredi A, Nieri G, Muratori P, Pfanner C, Milone A.
    J Clin Psychopharmacol; 2017 Oct 03; 37(5):590-594. PubMed ID: 28806385
    [Abstract] [Full Text] [Related]

  • 7. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH, Merry SN, Hetrick SE, Stasiak K.
    Cochrane Database Syst Rev; 2012 Sep 12; (9):CD008559. PubMed ID: 22972123
    [Abstract] [Full Text] [Related]

  • 8. National Patterns of Commonly Prescribed Psychotropic Medications to Young People.
    Sultan RS, Correll CU, Schoenbaum M, King M, Walkup JT, Olfson M.
    J Child Adolesc Psychopharmacol; 2018 Apr 12; 28(3):158-165. PubMed ID: 29376743
    [Abstract] [Full Text] [Related]

  • 9. Correlates of incident bipolar disorder in children and adolescents diagnosed with attention-deficit/hyperactivity disorder.
    Jerrell JM, McIntyre RS, Park YM.
    J Clin Psychiatry; 2014 Nov 12; 75(11):e1278-83. PubMed ID: 25470092
    [Abstract] [Full Text] [Related]

  • 10. Impact of atypical antipsychotic use among adolescents with attention-deficit/hyperactivity disorder.
    Sikirica V, Pliszka SR, Betts KA, Hodgkins P, Samuelson TM, Xie J, Erder MH, Dammerman RS, Robertson B, Wu EQ.
    Am J Manag Care; 2014 Sep 12; 20(9):711-21. PubMed ID: 25365746
    [Abstract] [Full Text] [Related]

  • 11. Genetic, Clinical, and Sociodemographic Factors Associated With Stimulant Treatment Outcomes in ADHD.
    Brikell I, Wimberley T, Albiñana C, Pedersen EM, Vilhjálmsson BJ, Agerbo E, Demontis D, Børglum AD, Schork AJ, LaBianca S, Werge T, Mors O, Hougaard DM, Thapar A, Mortensen PB, Dalsgaard S.
    Am J Psychiatry; 2021 Sep 01; 178(9):854-864. PubMed ID: 34154395
    [Abstract] [Full Text] [Related]

  • 12. α2-Adrenergic Agonists or Stimulants for Preschool-Age Children With Attention-Deficit/Hyperactivity Disorder.
    Harstad E, Shults J, Barbaresi W, Bax A, Cacia J, Deavenport-Saman A, Friedman S, LaRosa A, Loe IM, Mittal S, Tulio S, Vanderbilt D, Blum NJ.
    JAMA; 2021 May 25; 325(20):2067-2075. PubMed ID: 33946100
    [Abstract] [Full Text] [Related]

  • 13. Treatment of Young People With Antipsychotic Medications in the United States.
    Olfson M, King M, Schoenbaum M.
    JAMA Psychiatry; 2015 Sep 25; 72(9):867-74. PubMed ID: 26132724
    [Abstract] [Full Text] [Related]

  • 14. Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.
    Guevara J, Lozano P, Wickizer T, Mell L, Gephart H.
    Pediatrics; 2002 May 25; 109(5):733-9. PubMed ID: 11986429
    [Abstract] [Full Text] [Related]

  • 15. Prescription Stimulant Use During Pregnancy and Risk of Neurodevelopmental Disorders in Children.
    Suarez EA, Bateman BT, Hernandez-Diaz S, Straub L, McDougle CJ, Wisner KL, Gray KJ, Pennell PB, Lester B, Zhu Y, Mogun H, Huybrechts KF.
    JAMA Psychiatry; 2024 May 01; 81(5):477-488. PubMed ID: 38265792
    [Abstract] [Full Text] [Related]

  • 16. Overlapping Prescriptions of Stimulants for Children and Adolescents With Attention-Deficit Hyperactivity Disorder.
    Chen CY, Yeh HH, Fang SY, Wu EC, Chang IS, Lin KM.
    Psychiatr Serv; 2012 Oct 01; 63(10):1011-8. PubMed ID: 22911441
    [Abstract] [Full Text] [Related]

  • 17. Psychosis with Methylphenidate or Amphetamine in Patients with ADHD.
    Moran LV, Ongur D, Hsu J, Castro VM, Perlis RH, Schneeweiss S.
    N Engl J Med; 2019 Mar 21; 380(12):1128-1138. PubMed ID: 30893533
    [Abstract] [Full Text] [Related]

  • 18. Use and Characteristics of Antipsychotic/Methylphenidate Combination Therapy in Children and Adolescents with a Diagnosis of Attention-Deficit/Hyperactivity Disorder.
    Scholle O, Banaschewski T, Enders D, Garbe E, Riedel O.
    J Child Adolesc Psychopharmacol; 2018 Mar 21; 28(6):415-422. PubMed ID: 29768038
    [Abstract] [Full Text] [Related]

  • 19. Determinants of initial pharmacological treatment for youths with attention-deficit/hyperactivity disorder.
    Chen CY, Gerhard T, Winterstein AG.
    J Child Adolesc Psychopharmacol; 2009 Apr 21; 19(2):187-95. PubMed ID: 19364296
    [Abstract] [Full Text] [Related]

  • 20. ADHD Treatment in Primary Care: Demographic Factors, Medication Trends, and Treatment Predictors.
    Hauck TS, Lau C, Wing LLF, Kurdyak P, Tu K.
    Can J Psychiatry; 2017 Jun 21; 62(6):393-402. PubMed ID: 28103079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.